Hypomagnesaemia and risk for metabolic glucose disorders: a 10‐year follow‐up study
- 16 May 2008
- journal article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 38 (6), 389-396
- https://doi.org/10.1111/j.1365-2362.2008.01957.x
Abstract
Background Although several lines of evidence suggest that hypomagnesaemia is a risk factor for developing type 2 diabetes, there are no studies regarding the association between hypomagnesaemia and the risk for developing impaired fasting glucose (IFG) or impaired glucose tolerance (IGT). Our objective was to examine the association between serum magnesium levels and the risk for developing IFG, IGT and type 2 diabetes. Materials and methods A total of 1122 individuals (20–65 years of age) were enrolled between 1996 and 1997, and 817 individuals re-examined about 10 years later. New-onset IFG (5·6–7·0 mmol L−1 fasting glucose), IGT (7·8–11·1 mmol L−1 glucose 2-h postload), and type 2 diabetes were determined from the number of subjects who had these conditions at the second examination without evidence that they were present at the first one. The relative risk of new-onset metabolic glucose disorders and diabetes (dependent variables) was computed using Poisson regression model adjusted for age, sex, family history of diabetes, waist circumference and homeostasis model assessment for insulin resistance index. Serum magnesium levels of < 0·74 mmol L−1 (independent variable) defined the exposed group. Results At baseline, 420 (51·4%) individuals had hypomagnesaemia. New-onset IFG and IGT was identified in 276 (33·8%) individuals. The relative risk for IFG, IGT and IFG + IGT was 1·11 (95% confidence interval, 0·5–5·1), 1·38 (95% confidence interval, 1·1–6·3) and 1·49 (95% confidence interval, 1·1–4·9), respectively. New-onset diabetes was identified in 78 (9·5%) individuals (relative risk 2·54; 95% confidence interval, 1·1–4·1). Conclusions Hypomagnesaemia is independently associated with the development of IGT, IFG + IGT and type 2 diabetes, but not with the development of IFG.Keywords
This publication has 26 references indexed in Scilit:
- Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistanceArchives of Biochemistry and Biophysics, 2007
- Hypomagnesemia, oxidative stress, inflammation, and metabolic syndromeDiabetes/Metabolism Research and Reviews, 2006
- Diabetes and cardiovascular disease: the road to cardioprotectionHeart, 2005
- Complementary Therapies for Diabetes: The Case for Chromium, Magnesium, and AntioxidantsArchives of Medical Research, 2005
- Insights into the molecular nature of magnesium homeostasisAmerican Journal of Physiology-Renal Physiology, 2004
- Impaired glucose tolerance is a more advanced stage of alteration in the glucose metabolism than impaired fasting glucoseJournal of Diabetes and its Complications, 2001
- The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressureArchives of Internal Medicine, 1997
- The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureArchives of Internal Medicine, 1997
- Magnesium deficiency and glucose metabolism in rat adipocytesMetabolism, 1996
- Fasting plasma magnesium concentrations and glucose disposal in diabetes.BMJ, 1984